Landmark Bio
Landmark Bio is an advanced therapy contract development and manufacturing organization dedicated to translating groundbreaking research into life-changing therapies.
HLA Protein Technologies Inc.
HLA Protein Technologies develops and manufactures validated soluble HLA Class I & II molecules and related services — quantitative peptide binding, epitope mapping, immune-target validation, and transplant antibody assay development for the development of immunotherapeutics and vaccines.
BPS Bioscience Inc.
BPS Bioscience provides 4000+ recombinant proteins, cell lines, lentiviruses, and assay services, specializing in immunotherapy, epigenetics, CRISPR, and more to accelerate drug discovery.
Pharmaron, Inc
Pharmaron is a premier life science service provider offering comprehensive research, development, and manufacturing service capabilities throughout the drug discovery, preclinical, clinical development, and commercialization process for small molecules, biologics, and CGT products.
Concept Life Sciences
Concept Life Sciences is a UK-based drug discovery CRO, helping global pharma and biotech companies accelerate their drug candidate to clinic by offering integrated drug discovery programs.
Lonza Group AG
Lonza Bioscience Solutions provides life science researchers with the tools they need to develop and test critical drugs and therapies, from basic research to final product release.
Alpha Lifetech Inc.
Alpha Lifetech Inc. is a premier supplier of antibodies, proteins, ELISA kits, and related biological reagents, there are over 20,000+ products in stock with various specifications to meet customer needs. The company was founded by a group of scientists with extensive experience in protein expression, antibody development, library construction.
KromaTiD, Inc.
KromaTiD uses single-cell, hybridization-based analysis to help gene and cell therapy developers bolster safety data for both research and regulatory filings.
Precision for Medicine
Precision for Medicine is an industry-leading global CRO, specifically designed to apply a biomarker-focused, precision medicine approach to therapeutic development.
Certis Oncology Solutions, Inc.
Certis explores options for precision therapies beyond the current standard of care, and partners with pharmaceutical companies to develop the next generation of targeted oncology therapeutics.
Lonza Bioscience
Lonza Bioscience Solutions provides researchers with tools to develop and test disease-treating drugs from research to product release.
Crown Bioscience
Find out how Crown Bioscience is advancing drug development and cancer research in our webinars, articles, and interviews.
